Montelin, Myca .
HRN: 24-08-13 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/22/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
11/22/2023
11/29/2023
IVT
110mg
Q24
Sepsis/PCAP
Checking Final Appropriateness
Indication: Empiric Type of Infection: PneumoniaUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes